神經復健設備市場規模、佔有率和成長分析（按類型、應用、最終用戶和地區）- 產業預測 2025-2032

神經復健設備市場規模預計在 2023 年達到 16 億美元，並從 2024 年的 17.3 億美元成長到 2032 年的 33.1 億美元，預測期內（2025-2032 年）的複合年成長率為 8.4%。

由於對中風、多發性硬化症和帕金森氏症等神經系統疾病的有效復健解決方案的需求不斷增加，神經復健設備市場正在蓬勃發展。這種成長是由於人口老化和生活方式的改變導致這些疾病的盛行率不斷增加。神經復健設備提供標靶治療，以提高患者的獨立性和功能能力。然而，這個市場面臨的挑戰包括需要持續研究以提高設備的有效性和易用性、高成本以及有限的報銷選擇。然而，人工智慧和機器人等技術的進步為改善神經復健結果提供了重大機會。總體而言，在技術創新和不斷成長的患者群體的推動下，美國神經復健設備市場預計未來幾年將保持強勁成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究分析

神經復健設備市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• 神經機器人設備
• 非侵入式刺激器
• 腦機介面

神經復健設備市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 中風
• 帕金森氏症
• 多發性硬化症
• 脊髓損傷
• 創傷性腦損傷
• 腦性麻痹
• 其他

神經復健設備市場規模（按最終用戶和複合年成長率分類）（2025-2032）

• 市場概況
• 復健中心
• 醫院
• 診所

神經復健設備市場規模（依地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Medtronic（US）
• Abbott Laboratories（US）
• Boston Scientific Corporation（US）
• Stryker Corporation（US）
• Smith & Nephew plc（UK）
• Ekso Bionics Holdings, Inc.（US）
• Bioxtreme Robotics Rehabilitation（Italy）
• ReWalk Robotics Ltd.（Israel）
• Neurostyle Pte. Ltd.（Singapore）
• Kinova Robotics（Canada）
• Neuro Rehab VR（US）
• Tyromotion GmbH（Austria）
• Neofect（South Korea）
• Enraf-Nonius（Netherlands）
• Hobbs Rehabilitation（UK）
• Motek Medical BV（Netherlands）

結論和建議

Neurorehabilitation Devices Market size was valued at USD 1.6 billion in 2023 and is poised to grow from USD 1.73 billion in 2024 to USD 3.31 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The neurorehabilitation devices market is expanding rapidly to meet the rising demand for effective rehabilitation solutions for neurological disorders, including stroke, multiple sclerosis, and Parkinson's disease. Contributing to this growth is the increasing prevalence of these conditions, driven by an aging population and shifting lifestyles. Neurorehabilitation devices offer targeted therapies that enhance patient independence and functional abilities. However, the market faces challenges such as the need for ongoing research to improve device effectiveness and usability, along with high costs and limited reimbursement options. Nonetheless, advancements in technologies like artificial intelligence and robotics present significant opportunities for enhanced neurorehabilitation outcomes. Overall, the U.S. neurorehabilitation devices market is projected to sustain robust growth in the coming years, driven by innovations and an expanding patient base.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurorehabilitation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurorehabilitation Devices Market Segments Analysis

Global Neurorehabilitation Devices Market is segmented by Type, Application, End User and region. Based on Type, the market is segmented into Neuro-Robotic Devices, Non-Invasive Stimulators and Brain-Computer Interfaces. Based on Application, the market is segmented into Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy and Others. Based on End User, the market is segmented into Rehabilitation Centers, Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurorehabilitation Devices Market

A key driver of the neurorehabilitation devices market is the ongoing technological advancements that have emerged in recent years. Significant progress in fields such as robotics, virtual reality, wearable sensors, and brain-computer interfaces has led to the creation of more advanced and effective neurorehabilitation devices. These innovations facilitate targeted therapies and personalized rehabilitation solutions tailored to individual patient needs. For instance, devices such as the EksoGT exoskeleton developed by Ekso Bionics and the ReWalk system from ReWalk Robotics are specifically designed to aid individuals with mobility challenges, enhancing their ability to walk and improving overall motor skills. These advancements are revolutionizing the approach to neurorehabilitation.

Restraints in the Neurorehabilitation Devices Market

A significant challenge facing the neurorehabilitation devices market is the elevated cost linked to these technologies. The use of advanced innovations like robotics and brain-computer interfaces drives up the price of these devices. Furthermore, the need for specialized knowledge to properly utilize such equipment adds to the overall expense of treatment. This financial burden can restrict access to neurorehabilitation devices, especially in areas where healthcare resources are scarce or insurance coverage is insufficient. Consequently, the economic barrier poses a considerable limitation, hindering the widespread adoption and availability of these crucial rehabilitation solutions.

Market Trends of the Neurorehabilitation Devices Market

The neurorehabilitation devices market is increasingly trending towards tele-rehabilitation solutions, driven by their ability to provide effective remote therapy options. This shift has accelerated in the wake of the COVID-19 pandemic, as traditional in-person rehabilitation faced interruptions, prompting both patients and clinicians to embrace digital alternatives. Tele-rehabilitation enhances accessibility and convenience, enabling patients to engage in rehabilitation sessions from the comfort of their homes while facilitating continuous monitoring by healthcare professionals. This trend not only promotes personalized care but also expands market opportunities for innovative telehealth technologies, positioning tele-rehabilitation as a cornerstone for the future of neurorehabilitation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Neurorehabilitation Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Neuro-Robotic Devices
• Non-Invasive Stimulators
• Brain-Computer Interfaces

Global Neurorehabilitation Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Brain Stroke
• Parkinson's Disease
• Multiple Sclerosis
• Spinal Cord Injury
• Traumatic Brain Injury
• Cerebral Palsy
• Others

Global Neurorehabilitation Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Rehabilitation Centers
• Hospitals
• Clinics

Global Neurorehabilitation Devices Market Size & CAGR (2025-2032)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ekso Bionics Holdings, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioxtreme Robotics Rehabilitation (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReWalk Robotics Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurostyle Pte. Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kinova Robotics (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuro Rehab VR (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tyromotion GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neofect (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enraf-Nonius (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hobbs Rehabilitation (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Motek Medical B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations